Transduction of Salivary Gland Acinar Cells with a Novel AAV Vector 44.9.
AAV44.9
AAVRh10
acinar cells
salivary gland
Journal
Molecular therapy. Methods & clinical development
ISSN: 2329-0501
Titre abrégé: Mol Ther Methods Clin Dev
Pays: United States
ID NLM: 101624857
Informations de publication
Date de publication:
11 Dec 2020
11 Dec 2020
Historique:
received:
06
04
2020
accepted:
09
10
2020
entrez:
9
12
2020
pubmed:
10
12
2020
medline:
10
12
2020
Statut:
epublish
Résumé
The loss of salivary gland function caused by radiation therapy of the head and neck or autoimmune disease such as Sjögren's syndrome is a serious condition that affects a patient's quality of life. Due to the combined exocrine and endocrine functions of the salivary gland, gene transfer to the salivary glands holds the potential for developing therapies for disorders of the salivary gland and the expression of therapeutic proteins via the exocrine pathway to the mouth, upper gastrointestinal tract, or endocrine pathway, systemically, into the blood. Recent clinical success with viral vector-mediated gene transfer for the treatment of irradiation-induced damage to the salivary glands has highlighted the need for the development of novel vectors with acinar cell tropism able to result in stable long-term transduction. Previous studies with adeno-associated virus (AAV) focused on the submandibular gland and reported mostly ductal cell transduction. In this study, we have screened AAV vectors for acinar cell tropism in the parotid gland utilizing membrane-tomato floxed membrane-GFP transgenic mice to screen CRE recombinase encoding AAV vectors of different clades to rapidly identify capsid isolates able to transduce salivary gland acinar cells. We determined that AAVRh10 and a novel isolate found as a contaminant of a laboratory stock of simian adenovirus SV15, AAV44.9, are both able to transduce parotid and sublingual acinar cells. Persistence and localization of transduction of these AAVs were tested using vectors encoding firefly luciferase, which was detected 6 months after vector administration. Most luciferase expression was localized to the salivary gland compared to that of distal organs. Transduction resulted in robust secretion of recombinant protein in both blood and saliva. Transduction was species specific, with AAVRh10 having stronger transduction activity in rats compared with AAV44.9 or AAV2 but weaker in human primary salivary gland cells. This work demonstrates efficient transduction of parotid acinar cells by AAV that resulted in secretion of recombinant protein in both serum and saliva.
Identifiants
pubmed: 33294494
doi: 10.1016/j.omtm.2020.10.006
pii: S2329-0501(20)30210-2
pmc: PMC7689275
doi:
Types de publication
Journal Article
Langues
eng
Pagination
459-466Informations de copyright
© 2020 The Authors.
Références
J Virol. 2008 Feb;82(3):1399-406
pubmed: 18045941
J Virol. 2004 Jun;78(12):6509-16
pubmed: 15163744
J Biol Chem. 2001 Jun 8;276(23):20610-6
pubmed: 11262413
J Virol. 2012 Jul;86(13):7326-33
pubmed: 22514350
Hum Gene Ther. 2011 Jan;22(1):84-92
pubmed: 20977345
Hum Gene Ther. 2002 Jan 20;13(2):287-98
pubmed: 11812284
J Virol. 2001 Aug;75(15):6884-93
pubmed: 11435568
Arthritis Res Ther. 2012 Feb 27;14(1):R40
pubmed: 22369699
J Dent Res. 2015 Feb;94(2):304-11
pubmed: 25416669
J Immunol Methods. 2006 May 30;312(1-2):12-9
pubmed: 16624319
Oral Dis. 2012 May;18(4):365-74
pubmed: 22212434
PLoS One. 2011 May 12;6(5):e19962
pubmed: 21589878
Gene Ther. 2006 Apr;13(7):594-601
pubmed: 16341060
J Virol. 2006 Dec;80(23):11556-70
pubmed: 16971437
Nat Biotechnol. 2009 Jan;27(1):59-65
pubmed: 19098898
Mol Ther. 2005 Mar;11(3):435-43
pubmed: 15727940
PLoS One. 2012;7(7):e40074
pubmed: 22808093
Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13552-7
pubmed: 21808006
Mol Ther. 2009 Jul;17(7):1187-96
pubmed: 19367261
Am J Physiol Cell Physiol. 2009 Dec;297(6):C1347-57
pubmed: 19794147
Mol Biol Cell. 2019 Feb 1;30(3):324-332
pubmed: 30540520
J Virol. 2006 Sep;80(18):9093-103
pubmed: 16940521
PLoS One. 2010 Mar 09;5(3):e9336
pubmed: 20231878
Hum Gene Ther. 2007 Feb;18(2):142-50
pubmed: 17328682
Virology. 2010 Jul 20;403(1):26-36
pubmed: 20444480
Hum Gene Ther. 1998 Dec 10;9(18):2777-85
pubmed: 9874275
Mol Ther. 2014 Apr;22(4):821-7
pubmed: 24304965
Genesis. 2007 Sep;45(9):593-605
pubmed: 17868096
J Biol Chem. 2011 Apr 15;286(15):13532-40
pubmed: 21330365
J Virol. 2010 Dec;84(24):12945-57
pubmed: 20861247
Lab Invest. 2011 Jan;91(1):54-62
pubmed: 20856230
J Cell Biol. 2017 Jul 3;216(7):1925-1936
pubmed: 28600434
J Virol. 2004 Jun;78(12):6381-8
pubmed: 15163731
Am J Respir Cell Mol Biol. 2006 Jan;34(1):56-64
pubmed: 16195538
Mol Ther. 2006 Mar;13(3):506-16
pubmed: 16368273
Expert Opin Biol Ther. 2015;15(10):1443-54
pubmed: 26149284
Proc Natl Acad Sci U S A. 2016 May 17;113(20):5694-9
pubmed: 27140635
Oral Dis. 2019 Mar;25(2):403-415
pubmed: 29383862
J Gene Med. 2009 Jun;11(6):506-14
pubmed: 19326368